A Single-Center Retrospective Study to Compare the Efficacy and Safety of Modified FOLFIRINOX with S-1 as Adjuvant Chemotherapy in 71 Patients with Resected Pancreatic Carcinoma

BACKGROUND: Studies are ongoing to determine the optimal adjuvant chemotherapy (ACT) for resected pancreatic carcinoma (PC). FOLFIRINOX is a chemotherapy regimen including oxaliplatin, irinotecan, leucovorin, and 5-fluorouracil (5-FU). S-1 is a fluoropyrimidine derivative widely used as ACT for gast...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Linhua, Tang, Chengwu, Feng, Wenming, Dai, Hanbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2022
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229892/
https://www.ncbi.nlm.nih.gov/pubmed/35718990
http://dx.doi.org/10.12659/MSM.937136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229892/
https://www.ncbi.nlm.nih.gov/pubmed/35718990
http://dx.doi.org/10.12659/MSM.937136

Ejemplares similares